Revamping the FDA

Revamping the FDA

The Journal of Life Sciences

Agency needs to adopt new tools to do its job in the 21st century.

Peter Pitts, president of the Center for Medicine in the Public Interest and a former FDA associate commissioner, argues that as the FDA enters its second hundred years, its mission must change to both protect and advance the public health. And in order to do that, the agency that regulates upwards of 25 percent of the U.S. economy needs new tools, new expertise and more funding.

Featured

Death Panel Siding
August 25, 2010  
Better Tools
August 23, 2010  
Attacking a Crisis Early in the Cost Curve
August 20, 2010  

Stay Informed

Receive latest news & event updates
Provide email below:


Bookmark and Share